Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
- B5864 Fruquintinib(HMPL-013)Target: VEGFRSummary: Potent and selective inhibitor of VEGFR 1, 2, 3
- B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR).
- B6199 BFH772Summary: VEGFR2 inhibitor
- B7800 BAW2881 (NVP-BAW2881)Summary: VEGFR inhibitor
- C3342 MAZ51Target: VEGFRSummary: VEGFR3 antagonist
- C3415 Tivozanib (hydrate)Summary: VEGFR inhibitor, orally available
- C3730 AAL-993Summary: VEGF receptors inhibitor
- C4603 VEGFR Tyrosine Kinase Inhibitor II1 CitationSummary: VEGFR inhibitor
- B2301 SAR131675Summary: VEGFR3 inhibitor,selective and ATP-competitve
- B1494 Tyrphostin 9Summary: Selective EGFR/PDGFR inhibitor